# Day 28: Milestone 06-03: Drug-Drug Interaction (DDI) & Clinical Safety Engine

**Date:** October 15, 2026  
**Milestone:** 06-03  
**Primary Commit:** `88186c1: feat(api): expose prescription safety check endpoint and clinician override audit log`  

---

## 1. Objectives

Building on the e-Prescription Authoring and FHIR R4 MedicationRequest engine established on Day 27, Day 28 engineered the **Clinical Decision Support (CDS) Safety Engine**. The engine provides real-time pharmacological surveillance to detect adverse drug events, life-threatening drug-drug interactions (DDIs), patient hypersensitivity/allergy cross-reactivities, and clinical condition contraindications prior to prescription signing.

The primary architectural goals were:
1. **Clinical Decision Support Knowledge Base:** Establish a rule evaluation engine featuring 10 curated clinical drug-drug interaction pairs graded by severity (`critical`, `major`, `moderate`).
2. **Allergy & Hypersensitivity Cross-Reactivity:** Implement class-based cross-matching against documented patient allergies (beta-lactam/penicillins, sulfonamides, and NSAIDs).
3. **Condition Contraindication Detection:** Cross-reference active patient conditions from the longitudinal problem list against drug clearance mechanisms (chronic kidney disease, active peptic ulcer disease, and severe asthma).
4. **REST API & Clinician Override Governance:** Expose `POST /api/v1/patients/{patient_id}/prescriptions/safety-check` returning ranked alerts, risk summaries, and requiring explicit clinical override justification when critical or major risks are detected.

---

## 2. Engineering Work Completed

### Pharmacological Knowledge Base & CDS Rule Engine (`app/services/cds_rules.py`)
- Defined clinical decision support alert taxonomies:
  - `CDSSeverity`: `critical` (contraindicated, life-threatening), `major` (serious adverse event risk), `moderate` (monitoring / spacing required).
  - `CDSAlertType`: `drug-drug`, `drug-allergy`, `drug-condition`.
- Codified 10 high-risk clinical DDI interaction rules:
  1. **Warfarin + Aspirin / NSAIDs (`CRITICAL`):** Synergistic antiplatelet/anticoagulant effect causing severe gastrointestinal and internal hemorrhage.
  2. **ACE Inhibitors / ARBs + Potassium-Sparing Diuretics (`MAJOR`):** Aldosterone blockade causing life-threatening hyperkalemia and arrhythmias.
  3. **Metformin + Iodinated Radiocontrast (`CRITICAL`):** Contrast-induced nephropathy triggering fatal metformin-associated lactic acidosis (MALA).
  4. **Clopidogrel + Omeprazole (`MAJOR`):** CYP2C19 competitive inhibition attenuating clopidogrel active metabolite formation.
  5. **SSRIs/SNRIs + Tramadol (`MAJOR`):** Excessive central serotonergic transmission triggering Serotonin Syndrome and seizures.
  6. **Statins + Strong CYP3A4 Inhibitors (`MAJOR`):** Impaired statin hepatic clearance provoking rhabdomyolysis and myopathy.
  7. **Methotrexate + Penicillins / NSAIDs (`CRITICAL`):** Renal OAT transporter competitive inhibition causing methotrexate retention and fatal myelosuppression.
  8. **Levothyroxine + Multivalent Cations (`MODERATE`):** Chelation with calcium or iron in GI tract impairing absorption (requires 4-hour temporal separation).
  9. **Digoxin + Amiodarone (`MAJOR`):** P-glycoprotein clearance inhibition doubling serum digoxin concentrations.
  10. **Fluoroquinolones + Theophylline (`MAJOR`):** CYP1A2 inhibition precipitating theophylline toxicity and seizures.

### Allergy & Condition Evaluation (`app/services/cds_rules.py` & `app/services/cds_safety.py`)
- Implemented `evaluate_allergy_cross_sensitivity`:
  - Beta-Lactams: Flagged on documented penicillin allergy when prescribing amoxicillin, ampicillin, or piperacillin.
  - Sulfonamides: Flagged on documented sulfa allergy when prescribing sulfamethoxazole, trimethoprim-sulfa, or celecoxib.
  - NSAIDs/Aspirin: Flagged on documented aspirin sensitivity when prescribing ibuprofen, diclofenac, naproxen, or ketorolac.
- Implemented `evaluate_condition_contraindications`:
  - Chronic Kidney Disease (CKD): Contraindicates systemic NSAIDs due to renal prostaglandin inhibition and acute GFR reduction.
  - Active Peptic Ulcer Disease: Contraindicates NSAIDs and systemic corticosteroids due to perforation and GI bleeding risk.
  - Severe Asthma: Contraindicates non-selective beta-blockers (propranolol, timolol) due to refractory bronchial beta-2 blockade.

### Service Layer & REST Endpoints
- Implemented `CDSSafetyService.evaluate_prescription_safety`:
  - Queries database for active signed prescriptions (`MedicationRequestStatus.ACTIVE`) and active clinical conditions (`ClinicalStatus.ACTIVE`).
  - Merges reported supplemental allergies and conditions.
  - Deduplicates and ranks alerts by severity (`critical` first, then `major`, then `moderate`).
  - Computes `passed` (zero critical alerts) and `requires_override` flags.
- Exposed REST endpoint in `app/api/v1/endpoints/medication_requests.py`:
  - `POST /api/v1/patients/{patient_id}/prescriptions/safety-check` returning `APIResponse[SafetyCheckResponse]`.

---

## 3. Verification & Test Suite

Authored `backend/tests/test_cds_safety.py` covering:
- Unit tests for all 10 curated clinical DDI interaction pairs.
- Unit tests for allergy cross-reactivity and negative controls.
- Unit tests for condition contraindications and disease safety.
- Asynchronous service evaluation testing against active database entities.
- REST API endpoint verification with JWT authorization.

**Test Results:**
- `test_cds_safety.py`: 5 passed in 0.99s.
- Full backend test suite: **218 passed in 39.57s (100% passing)**.
